Authors: Collins JJ, Ahlgrimm M.
Publication Year: 2008
Citation: Int J Pharm Compounding 2008;12(7):123-127.
This paper highlights some counterarguments to an opinion piece by the American College of Obstetrics and Gynecologists, which has been widely quoted as evidence against the use of bioidentical hormones. The authors urge clinicians reading the ACOG opinion piece to ask themselves whether it really reflects clinical advances in the use of compounded and FDA-approved bioidentical hormones that have transformed the practice of hormone replacement therapy. They recommend that people read the original research, rather than quoting reviews and opinions that are not well founded in the literature.